Bausch Health - About the company
Bausch Health is a public company based in Laval (Canada), founded in 1960. It operates as a Developer of therapeutics for the treatment of multiple diseases. Bausch Health has raised an undisclosed amount in funding. The company has 2504 active competitors, including 861 funded and 630 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics.
Company Details
Developer of therapeutics for the treatment of multiple diseases. The company manufactures pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology, and more. The lead candidate of the company IDP-120 is used to treat acne. In 2023, the company recorded annual revenues of $8.15B and a net loss of $0.36B.
- Website
- www.bauschhealth.com/
- Email ID
- *****@bauschhealth.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
1960
Location
Laval, Canada
Stage
Public
Latest Funding Round
Investors
Ranked
82nd among 2504 active competitors
Annual Revenue
$8.72B as on Dec 31, 2017
Employee Count
2,704 as on Dec 01, 2025
Similar Companies
Exit Details
Public
Legal entities associated with Bausch Health
Bausch Health is associated with 6 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Salbe pharm s.r.o. CIN: 05651719 , Czech Republic, Active | Dec 21, 2016 | - | - | |
QC Company Investment s.r.o. CIN: 28562097 , Czech Republic, Active | Oct 13, 2008 | - | - | |
Bausch Health Companies Inc. CIN: 980448205 , United States, Active | Dec 31, 1999 | $9.62B (As on Dec 31, 2024) | 1867 (As on Dec 31, 2024) | - |
Vanos Company s.r.o. CIN: 09303235 , Czech Republic, Active | Jul 02, 2020 | - | - | |
BAUSCH HEALTH COMPANIES, INC. CIN: 330628076 , United States, Active | - | 859 (As on Dec 31, 2019) | - | |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. CIN: 885590 , United States, Active | $8.72B (As on Dec 31, 2017) | 808 (As on Dec 31, 2022) | - |
Bausch Health's IPO details
Bausch Health got listed on Jun 29, 1987.
Click here to take a look at Bausch Health's IPO in detail
Sign up to download Bausch Health's company profile
Bausch Health's funding and investors
Bausch Health has raised funding over 11 rounds. Its first funding round was on Mar 26, 2002. Bausch Health has 8 institutional investors.
Here is the list of recent funding rounds of Bausch Health:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 08, 2019 | 1055445 | Conventional Debt | 9227953 | 1716259 | 3661920 | 7295994 |
Nov 27, 2018 | 6882546 | Conventional Debt | 8085736 | 5160887 | 9974302 | 9600060 |
Jun 30, 2018 | 3523303 | Conventional Debt | 3954222 | 4448849 | 5439984 | 2152252 |
Access funding benchmarks and valuations. Sign up today!View details of Bausch Health's funding rounds and investors
Bausch Health's founders and board of directors
Founder? Claim ProfileBausch Health's employee count trend
Bausch Health has 2,704 employees as of Dec 25. Here is Bausch Health's employee count trend over the years:
Uncover Bausch Health's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bausch Health's Competitors and alternates
Top competitors of Bausch Health include Jazz Pharmaceuticals, Sana Biotechnology and C4 Therapeutics. Here is the list of Top 10 competitors of Bausch Health, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of genetically engineered cell therapies for multiple disorders | $821M | 75/100 | |
3rd | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 74/100 | |
4th | Juno Therapeutics 2013, Seattle (United States), Acquired | Global biopharmaceutical company discovering, developing, and delivering innovative medicines | $317M | 74/100 | |
5th | Blueprint Medicines 2008, Cambridge (United States), Acquired | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | 73/100 | |
6th | _1548135965397.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kronos Bio 2017, San Mateo (United States), Acquired | Developer of small molecule based therapeutics for cancer treatment | $271M | 72/100 | |
7th | MacroGenics 2000, Rockville (United States), Public | Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease | $126M | 72/100 | |
8th |  Harbour BioMed 2016, Shanghai (China), Public | Developer of antibody therapeutics in immunology and oncology disease | $313M | 71/100 | |
9th |  iTeos Therapeutics 2011, Cambridge (United States), Acquired | Developer of immunotherapy for treating cancer | $204M | 70/100 | |
10th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 70/100 | |
82nd |  Bausch Health 1960, Laval (Canada), Public | Developer of therapeutics for the treatment of multiple diseases | - | 63/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bausch Health's competitors? Click here to see the top ones
Bausch Health's Investments and acquisitions
Bausch Health has not made any investments yet. Bausch Health has made 21 acquisitions.Here is the list of latest three $acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 29, 2025 | Acquisition | 1998 | Cupertino (United States) | |
Feb 08, 2017 | Acquisition | 2015 | Colombo (Sri Lanka) | |
Jan 12, 2017 | Acquisition | 2005 | - |
_1571983406486.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Bausch Health
Reports related to Bausch Health
Here is the latest report on Bausch Health's sector:
News related to Bausch Health
Filter this listMedia has covered Bausch Health for a total of 37 events in the last 1 year, 18 of them have been about company updates and 6 about people movement.
•
Alembic Pharma gets U.S. FDA nod for generic antifungal drugThe Hindu•Feb 24, 2026•Alembic Pharmaceuticals, Bausch Health
•
•
Bausch Health Provides Update on RED-C Phase 3 Clinical TrialsPR Newswire•Jan 23, 2026•Bausch Health
•
•
Bausch Health Announces Offers to Exchange Certain Existing Senior Secured NotesWebDisclosure•Nov 24, 2025•Bausch Health
•
•
•
Goldman Sachs Group Inc. Raises Holdings in Bausch Health Cos Inc. $BHCMarketBeat•Sep 17, 2025•Bausch Health, Goldman Sachs
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Bausch Health
Explore our recently published companies
- Sciom.com - 2003 founded, Unfunded company
- Kagulex - Horsham based, 2023 founded, Unfunded company
- Mrigangi - 2018 founded, Unfunded company
- Foxypearljewelry - Houston based, 2020 founded, Unfunded company
- ThunderBurst Media - Dallas based, 2021 founded, Unfunded company
- Ekuom - Shanghai based, Unfunded company
